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Abstract 
Aims: NOS3 prevents neointima hyperplasia by still unknown mechanisms. To 
demonstrate the significance of endothelial Nitric Oxide in the polarization of infiltrated 
macrophages through the expression of MMP-13 in neoíntima formation.  
Methods and Results: After aortic endothelial denudation, NOS3-null mice show 
elevated neointima formation, detecting increased mobilization of LSK progenitor cells, 
and high ratios of M1 (proinflammatory) to M2 (resolving) macrophages, accompanied 
by high expression of, IL5, IL6, MCP1, VEGF, GM-CSF, IL-1 , and interferon-. In 
conditional c-Myc knockout mice, in which M2 polarization is defective, denuded aortas 
showed extensive wall thickening as well. Conditioned medium from NOS3-deficient 
endothelium induced extensive repolarization of M2 macrophages to an M1 phenotype, 
and vascular smooth muscle cells proliferated and migrated faster in conditioned 
medium from M1 macrophages. Among the different proteins participating in cell 
migration, MMP-13 was preferentially expressed by M1 macrophages. M1-mediated 
VSMC migration was inhibited when macrophages were isolated from MMP-13 
deficient mice, whereas exogenous administration of MMP-13 to VSMC, fully restored 
migration. Excess vessel wall thickening in mice lacking NOS3 was partially reversed 
by simultaneous deletion of MMP13, indicating that NOS3 prevents neointimal 
hyperplasia by preventing MMP13 activity. An excess of M1 polarized macrophages 
that coexpress MMP13 was also detected in human carotid samples from 
endarterectomized patients. Conclusions: These findings indicate that at least M1 
macrophage-mediated expression of MMP-13 in NOS3 null mice induces neointima 
formation following vascular injury, suggesting that MMP-13 may represent a new 
promising target in vascular disease.  
 
Abbreviations:  
NOS3: Endothelial Nitric Oxide Synthase 3. 
NOS2: Inducible Nitric Oxide Synthase 2.  
MAEC: Murine Aortic Endothelial Cells. 
VSMC: Vascular Smooth muscle Cells. 
MMP-13: Matrix Metalloproteinase-13. 
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Vascular stents and percutaneous balloon angioplasty, despite their undoubted 
benefits, often have adverse effects, including restenosis of the vessel wall 1, 2. Arterial 
wall restenosis is caused by mechanical disruption of the vascular endothelium, which, 
by unknown mechanisms, induces extensive smooth muscle and endothelial cell 
migration and proliferation, resulting in increased arterial wall thickness and a 
narrowing of the lumen 3-6.  
The increased cell migration, cell proliferation and platelet aggregation that lead to 
neointima formation are triggered by NO-dependent endothelial dysfunction 7. The 
ability of endothelial NOS (eNOS, NOS3) to limit these events was demonstrated by 
viral and non-viral transfection in rabbits with NOS3, which significantly reduced 
neointima formation and endothelial regeneration, and by pharmacological inhibition in 
rats 8-11.  
The early response to arterial injury involves the recruitment, infiltration and activation 
of M1 macrophages, which produce proinflammatory cytokines, chemokines, and 
basement-membrane-degrading extracellular-matrix metalloproteinases (MMPs), 
resulting in increased cell migration and proliferation. Polarization to M2 (resolving) 
macrophages induces the expression of several genes involved in wound healing and 
re-endothelization. Differentiated macrophages are thought to be able to switch 
between the M1 and M2 phenotypes, a phenomenon known as macrophage plasticity. 
This would imply that cells that initially promote an inflammatory response can later 
have anti-inflammatory properties, and suggests that controlling the signals that trigger 
macrophage polarization presents potential for the therapeutic regulation of neointima 
formation in injured vessels 12-15.  
Macrophage inducible NOS (iNOS, NOS2), drives the expression of several 
proinflammatory genes in M1 macrophages 16. Nitric Oxide induces the expression and 
activity of collagenase MMP13 17-2122, 23, which regulates proliferation and migration of 
several cell types. The effect of NO-mediated matrix metalloproteinase expression on 
neointima formation is largely unknown. Here we describe the contribution of 
macrophage polarization through MMP-13-mediated expression on neointimal 





Lack of NOS3 promotes neointima formation 
In order to explore the role of intimal derived endothelial NOS3 on neointimal 
formation, we used a non wire-surgical denudation procedure, to prevent destruction of 
smooth muscle cells from tunica media, and a wire denudation injury for validation 
purposes, in aortas from WT and NOS3 null mice. Over a 30-day period after 
endothelial denudation, aortas lacking NOS3 showed significant neointimal formation 
when compared with WT aortas in both procedures (Fig.1A).  
 
We calculated the intima, intima/media, lumen, total vessel areas and the amount of 
smooth muscle cells at the time points indicated finding significant differences between 
wild type and NOS3 null aortas at 15 and 30 days after denudation, revealing an 
impaired remodeling of NOS3 knockout mice. Endothelial regeneration was also 
defective in these mice (Fig.1A right panels). The protective effect of NOS3 was further 
verified in this model by intraperitoneal injection of the NO donor sodium nitroprusside 
(SNP) into NOS3 null mice, showing significant regression of the neointimal layer (Fig. 
1B), while in WT mice injection of the NOS inhibitor L-NAME increased intimal-media 
thickness, mimicking the effect of NOS3 gene deletion (Fig. 1C). SNP and L-NAME 
had no effect in endothelial denuded WT and NOS3 null mice respectively (Figs 1B, 
and 1C). 
 
Transplantation of NOS3 bone marrow into irradiated WT animals had no effect on 
neointima formation (Supplemental Fig. 1B), whereas transplantation of WT bone 
marrow into NOS3 deficient mice significantly reduced wall thickness, compared with 
NOS3 null mice transplanted with NOS3 null bone marrow, and with non 
irradiated/bone marrow transplanted NOS3 null mice (Supplemental Fig. 1C), 
indicating that bone marrow from NOS3 expressing mice may participate in the 
prevention of neointimal formation in response to endothelial injury.   
 
To explain why bone marrow from WT mice had such impact on NOS3 denuded 
aortas, we analyzed bone marrow LSK (multipotent hematopoietic progenitor cells) and 
myeloid progenitor cells from WT and NOS3 null animals, finding no differences in cell 
content between strains in basal conditions (Supplemental Fig. 1D). However, in 
response to injury, at 7 days after endothelial denudation, NOS3 knockout mice contain 
twice LSK progenitor cells respect to their WT counterparts in circulating blood 
(Supplemental Fig. 1E, left), indicating that in the absence of NOS3 more progenitor 
cells are mobilized, and thereby NOS3 may prevent neointimal formation by controlling 
the migration of bone marrow derived cells in response to endothelial denudation (Figs 
1 and Supplemental 1C). Nevertheless, no differences were detected in myeloid 
progenitor cell mobilization between mice (Supplemental Fig. 1E, right), suggesting a 
key role of lymphoid cell mobilization in NOS3 null mice.  
 
Lack of NOS3 induces accumulation of M1 pro inflammatory macrophages after 
denudation. 
 
Aortic denudation provoked an inflammatory response characterized by leukocyte 
infiltration into the vessels. No differences in CD68+ cell content  was observed in both 
strains, although in the absence of NOS3 there is an imbalance M1>M2 of pro 
inflammatory macrophages per lesional area (CD68+/iNOS+), whereas in WT aortas 
extensive M2 infiltrated macrophages at 14 days after injury (CD68+/MRC1+) were 
detected, thus contributing to the shortening of inflammation (Fig. 2A, and 
Supplemental Figure 2A). 
 
This was also evidenced in mice conditionally deficient for macrophage specific c-Myc 
expression (Fig. 2B), which blocks their polarization to the M2 phenotype 24, and in 
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which extensive aortic wall thickening and M1 macrophage accumulation, was also 
detected when compared to NOS3 WT mice (Fig. 2C, and Supplemental Figure 2B).  
 
 
Lack of NOS3 increases the levels of cytokines and chemokines that promote 
polarization and accumulation of proinflammatory M1 macrophages 
The data shown below explains why NOS3 prevents abnormal remodeling of the 
vessel wall, by dampening accumulation of proinflammatory vs resolving macrophages 
at the injured area. To investigate the role of NOS3-deficiency in the accumulation pro-
inflammatory macrophages, we first measured 20 cytokines in plasma collected from 
NOS3-WT and -null mice after aortic denudation at the times indicated (Fig. 3A). 
Increased levels of IL5, IL6 and MCP1 were detected in the first 24 h after denudation. 
By contrast, the levels of monocyte chemotractant MCSF and CCL5 proteins remained 
unchanged (Supplemental Figure 3). To address whether vascular endothelial cells are 
responsible of such profile, we analyzed cell culture supernatants collected from 
wounded NOS3-WT and -null MAEC monolayers. In these conditions, we also 
observed significant levels of proinflammatory cytokines and chemokines including, 
IL6, GM-CSF, VEGF, IFN and IL-1  in NOS3 null MAEC (Fig. 3B). 
 
 
To asses whether NOS3 deficiency may also induce M2 repolarization to an M1 
phenotype, we cultured WT M1- and M2-polarized bone marrow derived macrophages 
in conditioned medium from endothelial cells isolated from WT or NOS3-null mouse 
aortas. Conditioned medium from NOS3-null MAEC induced WT M2 polarized 
macrophages to express high levels of iNOS (Fig. 3C, upper panel), a classical marker 
of M1 proinflammatory activated macrophages (Fig. 3C bottom), together with marked 
levels of proinflammatory cytokine IL-6, when compared to the levels found in M2 
macrophages incubated with conditioned medium from WT MAEC, as detected by 
immunoblot (Fig. 3D). 
 
Taken together, lack of NOS3 induces pro-inflammatory macrophage accumulation by 
inducing M1 polarization, and repolarization of M2 macrophages to the M1 phenotype. 
 
M2 polarized macrophages slow VSMC proliferation and migration in the 
absence of NOS3 
VSMC proliferation and migration are key steps during neointimal formation. To test 
whether proinflammatory or resolving macrophages may have an effect on these 
processes, we incubated VSMC with conditioned medium from M1 and M2 polarized 
macrophages, finding that cells proliferate more and migrate faster with conditioned 
medium from M1 respect to M2 macrophages (Figs. 4A and B), and confirmed by 
exogenous administration the NO donor Sodium Nitroprusside to M2 polarized 
macrophages (Fig. 4C).  Interestingly M1 and exogenous M2 macrophages incubated 
with SNP, express high levels of MMP-13 mRNA, and secreted MMP-13, a protein 
implicated the migration of different cell types, when compared with polarized M2 
macrophages (Fig. 5A). To test whether macrophage mediated MMP-13 may regulate 
VSMC migration, we found no significant differences when macrophages were isolated 
from MMP-13 null mice (Fig. 5B), whereas exogenous administration of MMP-13 
restored the migratory phenotype (Fig. 5C). Taken together, M1 macrophage-mediated 
MMP-13 expression and activity induce VSMC migration in the absence of NOS3, 
shedding light about the mechanism by which NOS3 prevents neointimal formation.  
 
MMP13 expression regulates neointima hyperplasia in NOS3 injured vessels 
To test whether MMP-13 plays a role in the absence of NOS3, we generated a double 
NOS3/MMP-13 null mouse strain (Fig. 6A). While the absence of MMP-13 in NOS3 
expressing vessels (MMP-13 null mice), has no effect on neointima formation, lacking 
of MMP13 in the NOS3-null background (double NOS3/MMP-13 null mice), prevented 
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the aortic wall thickening seen in mice singly deficient for NOS3 30 days after 
endothelial aortic denudation (Fig. 6B).  
Transplantation of MMP-13 deficient bone marrow (either from MMP-13 null mice or 
double MMP-13/NOS3 knockout mice) into irradiated NOS3 null animals significantly 
reduced wall thickness, when compared with NOS3 null denuded aortas from non 
irradiated mice (Fig. 6C), indicating that MMP-13 expressing bone marrow derived cells 
may regulate neointimal formation in NOS3 null mice. 
Consistent with these findings, we detected high levels of MMP13 in cross sections of 
human aortic endarterectomies, together with high numbers of M1 (CD68+ iNOS+) 
polarized macrophages, as detected by confocal microscopy, and extensive neointimal 
hyperplasia, whereas in healthy human arteries, MMP-13 was barely detected (Fig. 
6D).  A proposed mechanism is shown in Supplemental Figure 4. 
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Discussion 
We show for the first time a matrix metalloproteinase as a target of NOS3 in the 
prevention of arterial neointimal hyperplasia. In the absence of NOS3, aortic 
endothelial disruption increases neointimal formation by promoting inflammation 
through an imbalance of M1 pro-inflammatory vs M2 resolving macrophage infiltrates, 
as result of significant accumulation of several pro-inflammatory cytokines in plasma 
and in endothelial cells from NOS3 deficient mice. M1 macrophages expressing MMP-
13 induce VSMC migration and proliferation, which are inhibited by M1 macrophages 
from MMP-13 null mice, and reversed by exogenous replacement of the missing 
protease. Furthermore, in double NOS3/MMP-13 deficient animals, lack of MMP-13 
was sufficient to prevent NOS3 null dependent neointimal formation. These data, 
together with the detection of extensive MMP-13 and M1 macrophage co-localization in 
human carotid endarcterectomies suggest MMP-13 as a new target to prevent human 
neointima hyperplasia.  
 
NOS3 prevents neointimal hyperplasia by limiting smooth muscle cell proliferation 
through as-yet undefined mechanisms 25. Arterial wall thickness is reduced in animal 
models of vascular injury by experimental approaches, including NO delivery by 
exogenous systemic or local administration of NO donors, or by viral-mediated 
transfection with NOS3 26, 27. However, no preclinical findings have been successfully 
implemented so far. Recent contributions elegantly describe the effect of NO in the 
ubiquitin-proteasome system 28-30, and the inhibition of the PDGF-surviving pathway 
during flow dependent vascular remodeling 31. Our work is the first to describe the role 
of NOS3 in the resolution of the immune response elicited in the vessel as result of 
endothelial denudation, identifying MMP-13 as a new target. 
 
After endothelial denudation, monocytes infiltrate in response to chemokines produced 
by a variety of cells, including immune and endothelial cells. M-CSF induces 
recruitment and differentiation of circulating monocytes into macrophages 13. The 
relevance of NOS3 to macrophage polarization has not been described so far. We 
found high levels of MCP-1 but not MCSF or CCL5 in plasma from NOS3 null mice, 
which may explain why monocyte recruitment is not affected by the absence of NOS3 
(Fig 2A, Total WT vs Total KO). However, the extensive expression of GM-CSF and 
IFN-gamma in the absence of NOS3, may explain the increased M1 proinflammatory 
macrophage polarization in these mice. 
 
The levels of interleukin-6 (IL-6) detected in vascular endothelium and plasma from 
NOS3 deficient denuded aortas are of significant interest. Over the past decade a large 
number of studies have demonstrated the importance of IL-6 in the progression of 
several inflammatory cardiovascular complications including unstable angina 32, 
coronary artery disease 33, and myocardial infarction 34. Coronary artery atherosclerosis 
is characterized by infiltration of activated macrophages, which generate high levels of 
IL-6. IL-6 is associated with increased mortality and also it serves to identify patients 
who may benefit most from early invasive strategies 35, 36. Furthermore, heart 
transplanted patients treated with simvastatin have low levels of IL-6 and improved 
levels of endothelial function 37. In this regard, inhibition of NO-mediated endothelial-
cell-driven relaxation is also strongly associated with increased levels of IL-6 38, 39. The 
levels of IL-6 found in denuded aortas from NOS3 null mice, further support the 
importance of IL-6 in the progression of neointimal formation. 
 
Matrix Metalloproteinases play an important role in the proliferation and migration of 
several cell types 18, 21, but the impact of NOS3-mediated MMP regulation of neointimal 
hyperplasia is yet unknown. Here we found that MMP-13 expression is increased in M1 
and NO-treated M2 macrophages, and induces migration of VSMC. MMP-13 null M1 
macrophages by contrast, had no effect on cell migration, unless exogenous MMP-13 




Macrophage expression of MMP-13 can be stimulated by pro-inflammatory cytokines, 
including endothelial IL6, which is strongly upregulated in the absence of NOS3, 
thereby promoting pro-inflammatory macrophage accumulation and increased 
macrophage-meditated MMP-13 expression, as detected, and as described in 
osteoblasts 40, fibroblasts 41, and cancer cells. High levels of MMP-13  were detected in 
carotid M1 infiltrated macrophages from patients undergoing  carotid endarcterectomy, 
with extensive neointimal hyperplasia.  To this regard, in patients undergoing 
percutaneous transluminal coronary angioplasty, neointima hyperplasia might be 
reduced by promoting M1 proinflammatory macrophage polarization to M2 resolving 
macrophages, in which expression of MMP-13 may play a pivotal role.  
Lack of MMP-13 neither induce neointimal hyperplasia in mice expressing NOS3, nor 
promotes M1-macrophage mediated VSMC migration, whereas increased aortic 
thickness shown in the absence of NOS3 is significantly reduced in double 
NOS3/MMP-13-deficient mice. Taking all these findings together, we propose that NO 
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Arterial wall restenosis may be caused by mechanical disruption of the vascular 
endothelium, inducing extensive smooth muscle and endothelial cell migration and 
proliferation, resulting in increased arterial wall thickness and a narrowing of the lumen. 
We show the impact that arterial endothelium expressing Nitric Oxide has in the 
modulation of the inflammatory response, elicited as result of endothelial disruption, in 
which endothelial nitric oxide synthase (NOS3) plays a critical role. NOS3 regulates 
macrophage polarization by preventing accumulation of pro-inflammatory 
macrophages, thereby contributing to the resolution of inflammation, and limiting 
restenosis. The significance of this finding is based in the effect on proinflammatory 
macrophage derived MMP-13 stimulation of smooth muscle cell proliferation and 
migration in the absence of NOS3, proposing MMP-13 as a novel target in the 




Figure 1. Lack of NOS3 promotes neointimal formation and impairs endothelial 
regeneration in denuded abdominal aortas A. Hematoxilin-Eosin (H&E) staining of 
aortic rings form WT and NOS3 knockout mice after endothelial denudation (0, 15, and 
30 days. Lower panels: WT and NOS3 aortic rings 30 days after wire injury (30W)). 
Right. Intima/media, lumen, intima, total vessele areas, endothelial cell and vascular 
smooth muscle cell counts of the same aortas (n=6 mice/group/day by triplicate. Mean 
± SD; *p<0.05 NOS3 KO 15 vs WT 15; **p<0.05 NOS3 KO 30 vs WT 30; ***p<0.05 
NOS3 KO 30W vs WT 30). Scale bars 50 m”.B. Intima/media area of denuded aortas 
from WT, NOS3 KO, and NOS3 KO mice weekly injected with 0.25 mg/kg/day of the 
NO donor sodium nitroprusside (SNP), or 50 mg/kg/day L-NAME as indicated (n=6 
mice/group/day by triplicate, mean ± SD; *p<0.05 NOS3 KO 30 vs NOS3 KO 30+SNP). 
C. Intima/media thickness of denuded aortas from WT mice injected with 50 mg/kg/day 
L-NAME, or 0.25 mg/Kg/day SNP as indicated (n=6 mice/group/day by triplicate, mean 
± SD; * p<0.05 WT 30 vs NOS3 KO 30; **p<0.05 WT 30 vs WT 30+L-NAME). 
 
Figure 2. Mice lacking NOS3 show increased levels of pro-inflammatory M1 
macrophages after aortic endothelial denudation. A. WT and NOS3 KO aortic 
CD68+/MRC1- (M1) and CD68+/MRC1+ (M2) infiltrated macrophages at 7 and 15 
days after endothelial denudation. Representative images show “en face” confocal 
microscopy detection of CD68+ (FITC, green) MRC1+(Cy3, red), and nuclei (Hoecht, 
blue). Data was graphically represented as percentage of lesional area, (n=6 
mice/group/day by triplicate; mean ± SD, * p<0.05 M1 WT 14 vs M1 NOS3 14, ** 
p<0.05 M2 WT 14 vs M2 NOS3 14. B. Bone marrow macrophages from WT and c-Myc 
conditional null mice were polarized to M1 and M2 macrophages, and the levels of c-
myc mRNA were evaluated by quantitative RT-PCR (n=6 mice/group by triplicate, 
mean ± SD * p<0.05 M2 WT vs M2 c-Myc KO). C.  Intima/media area of aortas 
collected from WT and c-Myc conditional null mice at 0, 15 and 30 days after 
endothelial denudation (n=6 mice/group by triplicate. mean ± SD; * p<0.05 WT 30 vs 
Myc 30).  
 
Figure 3. Vascular endothelium regulates macrophage polarization. A. Plasma 
levels of pro-inflammatory cytokines isolated from WT and NOS3 null mice after aortic 
endothelial denudation at the times indicated (n=3 mice/group/day by triplicate, mean ± 
SD *** p<0.05 WT vs NOS3 KO). B. Multiplex analysis of secreted cytokines from 
injured WT and NOS3-null endothelial cell monolayers, and collected at the times 
indicated (n=3 by triplicate, mean ± SD *** p<0.05 WT vs NOS3 KO). C. Upper. 
Expression of iNOS by qRT-PCR in polarized M1 and M2 macrophages, and incubated 
for 24h and 48h with conditioned medium from MAEC WT and NOS3 KO (n=3 by 
triplicate, mean ± SD * p<0.05 M1 24h vs M2 24h; ** p<0.05 M1 48h vs M2 48h). 
Bottom. qRT-PCR expression of iNOS from bone marrow macrophages 24 hours after 
polarization into M1, M2, and M2 treated macrophages with the NO donor SNP (n=3 by 
triplicate, mean ± SD * p<0.05 M1 vs M2; ** p<0.05 M1 vs M2+SNP). D. Expression of 
IL6 from M1 and M2 polarized macrophages and incubated for 24 or 48h with 
conditional medium from WT or NOS3 KO MAEC as indicated. Expression of GAPDH 
was assayed as control  (n=3 by triplicate). 
 
Figure 4. M1 macrophages regulate VSMC proliferation and. A. Proliferation of 
VSMC after 24 hours of incubation with conditioned medium from M1 and M2 polarized 
macrophages (n=3, by triplicate mean ± SD * p<0.05 Control  vs M1; ** p<0.05 M1 vs 
M2). B. VSMC monolayers were injured, and migration of cells was evaluated at the 
times indicated (n=3, by triplicate mean ± SD * p<0.05 M1 vs M2) Representative 
micrographs of migrating wounded cells taken at the times indicated are depicted. C. 
VSMC migration as in B, in which the contribution of exogenous NO administration 
 15 
(Sodium Nitropruside, SNP) to M2 polarized macrophages was evaluated (n=3, mean 
± SD * p<0.05 M2  vs M2+SNP). Scale bars 100 m. 
Figure 5. M1-mediated VSMC migration depends on macrophage-dependent 
MMP-13 expression. A. Expression of MMP-13 in polarized macrophages. 
Immunoblot detection of MMP-13 (upper), gelatin zymography (middle) from 
macrophage cell culture supernatants (upper), and macrophage MMP-13 mRNA 
detection (lower graph), 24 hours after polarization into M1, M2, or into M2 
macrophages and incubated with the NO donor SNP (n=3, by triplicate,  mean ± SD * 
p<0.05 M2 vs M2+SNP; ** p<0.05 M1 vs M2). B. VSMC migration in the presence of 
polarized M1, M2 and M2 +SNP macrophage supernatants isolated from MMP-13 null 
mice (n=3, by triplicate mean ± SD). C. VSMC migration as in B, in which cell 
monolayers were also incubated with exogenous recombinant active MMP-13 ((n=3, by 
triplicate, mean ± SD * p<0.05 MMP-13 KO M2 4h vs MMP-13 KO M2 + MMP-13 4h; ** 
p<0.05 MMP-13 KO M2  6h vs MMP-13 KO M2 + MMP-13 6h). 
 
Figure 6. Lack of MMP-13 prevents neointimal thickening of NOS3 null mice. A. 
DNA electrophoresis from WT and double NOS3- and MMP-13-deficient mice, showing 
the different allelic combinations, as indicated. B. Aortic intima/media thickness from 
WT, MMP-13-null mice, NOS3 null mice, and NOS3/MMP-13 null mice, 15 and 30 days 
after endothelial denudation (n=10 mice/group/day, by triplicate mean ± SD; * p<0.05 
NOS3 null 30 vs NOS3/MMP-13 null 30). C. Aortic intima/media thickness from a 30 
day injured and transplanted NOS3-deficient mice with bone marrow from MMP-13 null 
or double MMP-13/NOS3 null mice  (n=6 mice/group/day by triplicate. Mean ± SD * 
p<0.05 NOS3 healthy control (open bar) vs NOS3 KO denuded 30 days; ** p<0.05 
NOS3 KO denuded 30 days vs NOS3 KO irradiated/BM MMP-13 KO; *** p<0.05 NOS3 
KO denuded 30 days vs NOS3 KO irradiated/BM MMP-13/NOS3 KO). D. 
Immunohistochemical detection of MMP-13 in cross sections of carotid samples from 
endarcterectomized patients, and healthy mammary arteries.  The white box 
corresponds to the carotid magnified region as also shown. Scale bars: 50 m. Bottom. 
Confocal microscopy detection of CD68 (green, FITC), and NOS2 (red Cy3) in the 
same carotid section as above. Co-localization of both signals is represented in yellow 
(Merged). Arrows indicate co-localization of macrophage infiltrates and MMP13. 
 
 
 
 
 
